OCUL icon

Ocular Therapeutix

118 hedge funds and large institutions have $330M invested in Ocular Therapeutix in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+5
Holders Change %
+4.42%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
26
Increased
38
Reduced
30
Closed
21
Calls
$1M
Puts
$1.3M
Net Calls
-$296K
Net Calls Change
-$991K
Name Holding Trade Value Shares
Change
Shares
Change %
Mirae Asset Global Investments
126
Mirae Asset Global Investments
South Korea
-$163K -52,049 Closed
Two Sigma Advisers
127
Two Sigma Advisers
New York
-$106K -33,700 Closed
AG
128
Algert Global
California
-$80K -25,480 Closed
LCS
129
Levin Capital Strategies
New York
-$70.7K -22,500 Closed
IC
130
Ikarian Capital
Texas
-$67.8K -21,590 Closed
PA
131
Profund Advisors
Maryland
-$65.4K -20,827 Closed
ACS
132
Archford Capital Strategies
Illinois
-$62.8K -20,000 Closed
Allspring Global Investments
133
Allspring Global Investments
North Carolina
-$50.5K -16,081 Closed
Rafferty Asset Management
134
Rafferty Asset Management
New York
-$37.2K -11,837 Closed
Vontobel Holding
135
Vontobel Holding
Switzerland
-$31.4K -10,000 Closed
SC
136
Stephens Consulting
Michigan
-$12.6K -4,000 Closed
Belvedere Trading
137
Belvedere Trading
Illinois
-$3.95K -1,257 Closed
UIA
138
Ulland Investment Advisors
Minnesota
-$1K -250 Closed
MPWT
139
MassMutual Private Wealth & Trust
Connecticut
-$336 -107 Closed
Man Group
140
Man Group
United Kingdom
-$50.3K